Company Filing History:
Years Active: 2017-2020
Title: Innovations in Cancer Treatment by Adriana Ioana Colovai
Introduction
Adriana Ioana Colovai is a prominent inventor based in Dumont, NJ (US). She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancers expressing ILT3 or ILT3 ligands. With a total of 2 patents, her work is paving the way for new therapeutic approaches in oncology.
Latest Patents
Colovai's latest patents focus on innovative methods for diagnosing and treating cancers that express ILT3. One of her notable inventions involves using the expression of ILT3 ligand or ILT3 on specific cancer cells as a diagnostic tool. The methods provided in her patents include treating ILT3-ligand expressing cancers, such as T-cell acute lymphoblastic leukemia, by administering ILT3 or its extracellular domain conjugated to a cytotoxic agent. Additionally, her patents describe methods for treating cancers that express ILT3 on their surface, such as monocytic forms of acute myeloid leukemia (AML), through the use of anti-ILT3 antibodies conjugated to cytotoxic agents.
Career Highlights
Colovai is affiliated with Columbia University, where she continues her research and development in cancer therapies. Her work is characterized by a strong focus on innovative solutions that address critical challenges in cancer treatment.
Collaborations
Some of her notable coworkers include Nicole Suciu-Foca and George Vlad, who contribute to her research efforts and collaborative projects.
Conclusion
Adriana Ioana Colovai's contributions to cancer research through her patents and collaborations highlight her commitment to advancing medical science. Her innovative approaches are essential in the ongoing fight against cancer, offering hope for improved diagnostic and treatment options.